Genencor, Eastman to license ascorbic acid bioprocess to ADM

Genencor, Eastman to license ascorbic acid bioprocess to ADM

F O C U S Borealis restructures European activities Borealis, a leading manufacturer of polyolefins worldwide, plans to restructure its European activ...

30KB Sizes 0 Downloads 93 Views

F O C U S Borealis restructures European activities Borealis, a leading manufacturer of polyolefins worldwide, plans to restructure its European activities. The company aims to reduce the time required to launch new products. Borealis will reduce technical research within the group by around one-quarter. Borealis GmbH in Linz will remain the Polymer Design Centre with main focus on polypropylene (PP) and will start activities in the polyethylene (PE) segment. The business units Film & Fibre and Engineering Applications, including application technology laboratories, will remain in Linz (Austria). Kunststoffe, Feb 2003, 93 (2), 7 (in German)

Clariant offers better metallocene waxes Clariant is selling a new range of waxes which give improved dispersion of organic and inorganic pigments and carbon black in polymers. The new waxes are made using a new metallocene process which has been developed by Clariant, and can have their properties adjusted to suit each customer. Use of the new wax lowers the amounts of carbon black needed for dispersion in polyethylene and polypropylene for good conductivity and appearance.

O N

C ATA LY S T S

chemical and petrochemical worldwide are discussed. These include ethylene oxide catalysts, styrene catalysts, hydrogenation catalysts, and environmental catalysts & systems. Chemical Week, 26 Mar 2003, 165 (12), 28

Davy and Samsung to cooperate on EO-to-PDO Davy Process Technology and Samsung are to cooperate on developing a cobalt-based catalytic process for making 1,3-propanediol from ethylene oxide. Samsung has a patented process for the hydroesterification of ethylene oxide to a hydroxyester, and Davy has technology for purifying propanediol to the level required for making polytrimethylene terephthalate. The location of a demonstration plant is likely to be in Asia. Chemical Week, 2 Apr 2003, 165 (13), 16

DIC & Kyushu Univ forge comprehensive R&D alliance On 19 Mar 2003, Dainippon Ink & Chemical announced the formation of a comprehensive joint research agreement with Kyushu University. Brief details are given. Research areas include nano organic materials and catalysts for polymerisation. Japan Chemical Week, 27 Mar 2002, 44 (2214), 1-2

Double Liaison, Apr 2003, 1 (531), 66

Codexis extends collaboration with Rio Tinto Maxygen’s Codexis subsidiary has extended its collaboration with Rio Tinto to develop a bioprocess for carbon dioxide sequestration. Codexis has developed an enzymatic system that improves the rate of CO2 fixation. Rio Tinto will provide full R&D funding for the programme as well as potential royalty payments. Codexis will retain all commercialization rights to the technology outside energy production. Chemical Week, 5 Mar 2003, 165 (9), 7

CRI Catalyst Company profiled CRI Catalyst Company is profiled. The major products and services supplied by the company to the

MAY 2003

Diversa making recombinant protein using Asahi Glass technology Diversa, US, has started commercial production of feedstuff protein using Asahi Glass’s ASPEX genetic engineering process. This is the first practical application of the technology which uses Schizosaccharomyces pombe. Diversa recently obtained US FDA permission to produce the enzyme phytase, using the technology. Phytase increases the absorption of organic phosphorus in feedstuffs, resulting in the release of less phosphorous compounds into the environment. Asahi Glass plans to become Japan’s biggest contract supplier of proteins and forecasts that the market for consignment protein production will grow to Yen 200 bn by 2005. Japan Chemical Week, 20 Mar 2003, 44 (2213), 5

Genencor, Eastman to license ascorbic acid bioprocess to ADM Genencor and Eastman Chemical are in talks to license a biotech process for ascorbic acid to Archer Daniels Midland (ADM). The two companies jointly developed the biocatalytic process to make 2-ketogluconic acid, an ascorbic acid intermediate, from glucose. Talks are expected to be concluded by the end of 2003. Chemical Week, 5 Mar 2003, 165 (9), 7

Millennium Cell is bellwether company for hydrogen economy Millennium Cell Inc is currently developing systems for the early adopter markets of consumer electronics and standby power, including a disposable fuel cartridge for personal laptop computers, a model of which Dr Stephen S Tang, Millennium Cell President and CEO unveiled at the Strategic Research Institute’s annual fuel cell investors conference in Cherry Hill, NJ. The CEO stated that Millennium Cell is a bellwether company: all PEM and alkaline fuel cells require pure hydrogen stored safely and conveniently so licenses to this technology will precede fuel cell product launches. Tang outlined the consumer electronic market showing a viable, robust market for the Millennium Cell Hydrogen on Demand fuel system. He showed the model for the disposable fuel cartridge for the portable computer industry, the details of which are briefed in the article. In addition, he highlighted the company’s accomplishments in transportation with uses of Hydrogen on Demand in DaimlerChrysler and PSA Peugeot Citroen prototypes. He detailed the benefits of Millennium Cell’s Portable Hydrogen Generator, which features a 2-hour runtime at load of 1 kW on fuel cell in a compact ‘one-button operation’ with a disposable borate container. Press release from: Millennium Cell, One Industrial Way West, Eatontown, NJ 07724, USA. Tel: +1 732 542 4000. Fax: +1 732 542 4010. Website: http://www.millenniumcell.com (28 Mar 2003)

Millennium Cell receives patent on system for hydrogen generation Millennium Cell Inc has been awarded

3